Risk of renal stone formation induced by long-term bed rest could be decreased by premedication with bisphosphonate and increased by resistive exercise

International Journal of Urology

Volumn 15, Issue 7, 2008, Pages 630-635

  Okada, Atsushi ^a   Ohshima, Hiroshi ^b   Itoh, Yasunori ^a   Yasui, Takahiro ^a   Tozawa, Keiichi ^a   Kohri, Kenjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b JAPAN AEROSPACE EXPLORATION AGENCY   (Japan)

Author keywords

Bisphosphonate; Long term bed rest; Osteoporosis; Relative supersaturation; Renal stone

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; OXALIC ACID; PAMIDRONIC ACID; PHOSPHATE;

ABDOMINAL RADIOGRAPHY; ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BED REST; BONE MINERAL; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONTRACTURE; CONTROLLED STUDY; EXERCISE; HUMAN; MALE; NEPHROLITHIASIS; OSTEOPOROSIS; PHOSPHATE EXCRETION; PREMEDICATION; PRIORITY JOURNAL; RISK ASSESSMENT; STONE FORMATION; URINALYSIS;

ADULT; BED REST; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; EXERCISE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 47249151857     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02067.x     Document Type: Article

References (22)

1. Sato Y, Honda Y, Asoh T, Iwamoto J. Longitudinal study of bone and calcium metabolism and fracture incidence in spinocerebullar degeneration. Eur. Neurol. 2006 56 : 155 61.
2. Thomsen JS, Morukov BV, Vico L, Alexandre C, Saparin PI, Gowin W. Cancellous bone structure of iliac crest biopsies following 370 days of head-down bed rest. Aviat Space. Environ. Med. 2005 76 : 915 22.
3. Caudarella R, Vescini F, Buffa A, La Manna G, Stefoni S. Osteoporosis and urolithiasis. Urol. Int. 2004 72 (Suppl 1 17 19.
4. Caudarella R, Vescini F, Buffa A et al. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J. Nephrol. 2003 16 : 260 6.
5. Heilberg IP, Martini LA, Szejnfeld VL et al. Bone disease in calcium stone forming patients. Clin. Nephrol. 1994 42 : 175 82.
6. Waymack JP, Warden GD. Renal calculi in the burned child. Burns 1987 13 : 190 3.
7. Scharli AF, Rumlova E, Schubiger G. Immobilization hypercalciuria after limb fractures in children. Z. Klinderchir 1983 38 : 240 2.
8. Smith SM, Heer M. Calcium and bone metabolism during space flight. Nutrition 2002 18 : 849 52.
9. LeBlanc A, Schneider V, Shackelford L et al. Bone mineral and lean tissue loss after long duration space flight. J. Musculoskelet. Neuronal Interact. 2000 1 : 157 60.
10. Hwang TI, Hill K, Schneider V, Pak CY. Effect of prolonged bedrest on propensity for renal stone formation. J. Clin. Endocr. Metab. 1988 66 : 109.
11. Ruml LA, Dubois SK, Roberts ML, Pak CY. Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate. J. Bone Miner. Res. 1995 10 : 655 62.
12. Zerwekh JE, Odvina CV, Wuermser LA, Pak CY. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J. Urol. 2007 177 : 179 84.
13. Watanabe Y, Ohshima H, Mizuno K et al. Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J. Bone Miner. Res. 2004 19 : 1771 8.
14. Berg HE, Tesch PA. Force and power characteristics of a resistive exercise device for use in space. Acta Astronaut. 1998 42 : 219 30.
15. Finlayson B. Calcium stones: some physical and clinical aspects. In : Dacid DS (ed.). Calcium Metabolism in Renal Failure and Nephrolithiasis. John Wiley & Sons, New York, 1977 377 82.
16. Leach CS, Rambaut PC. Biochemical responses of the Skylab crewmen: an overview. In : Johnston RS, Dietlein LF (eds). Biomedical Results from Skylab. National Aeronautics and Space Administration, Washington DC, 1977 204 16.
17. Nicogossian AE, Huntoon CL, Pool SL. Overall physiological response to space flight. In : Nicogossian AE (ed). Space Physiology and Medicine, 2nd edn. Lea and Febiger, Philadelphia, PA, 1982 139 53.
18. Whitson PA, Pietrzyk RA, Sams CF. Urine Volume and its Effect on Renal Stone Risk in Astronauts. Aviat. Space Environ. Med. 2001 72 : 368 72.
19. Kohri K, Garside J, Blacklock NJ. The role of magnesium in calcium oxalate urolithiasis. Br. J. Urol. 1988 61 : 107 15.
20. Li MK, Blacklock NJ, Garside J. Effects of magnesium on calcium oxalate crystallization. J. Urol. 1985 133 : 123 5.
21. Pak CY. Citrate and renal calculi. Miner. Electrolyte Metab. 1987 13 : 257 66.
22. Khan SR. Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol. Res. 1995 23 : 71 9.